Freedom Investment Management Inc. bought a new position in SIGA Technologies, Inc. (NASDAQ:SIGA – Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 23,273 shares of the company’s stock, valued at approximately $157,000.
Several other institutional investors have also modified their holdings of the company. Vanguard Group Inc. grew its position in SIGA Technologies by 1.9% in the 1st quarter. Vanguard Group Inc. now owns 2,283,612 shares of the company’s stock worth $19,548,000 after purchasing an additional 41,515 shares during the last quarter. AltraVue Capital LLC boosted its position in shares of SIGA Technologies by 6.6% during the second quarter. AltraVue Capital LLC now owns 2,177,646 shares of the company’s stock worth $16,528,000 after buying an additional 134,450 shares during the period. Tidal Investments LLC bought a new position in SIGA Technologies in the 1st quarter worth approximately $157,000. Harbor Capital Advisors Inc. acquired a new stake in SIGA Technologies in the 3rd quarter valued at approximately $1,098,000. Finally, Allspring Global Investments Holdings LLC raised its stake in SIGA Technologies by 172.1% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 211,236 shares of the company’s stock valued at $1,426,000 after acquiring an additional 133,597 shares in the last quarter. Institutional investors own 55.40% of the company’s stock.
SIGA Technologies Stock Performance
Shares of SIGA stock opened at $7.28 on Monday. SIGA Technologies, Inc. has a 1 year low of $4.26 and a 1 year high of $12.83. The firm has a market capitalization of $519.83 million, a PE ratio of 6.07 and a beta of 0.89. The stock has a fifty day moving average of $6.94 and a two-hundred day moving average of $7.85.
About SIGA Technologies
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Read More
- Five stocks we like better than SIGA Technologies
- What Are Dividend Achievers? An Introduction
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- What Are the FAANG Stocks and Are They Good Investments?
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- Learn Technical Analysis Skills to Master the Stock Market
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Want to see what other hedge funds are holding SIGA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SIGA Technologies, Inc. (NASDAQ:SIGA – Free Report).
Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.